Papers by Michelle Samaniego
Cancer Causes & Control
Cancers
The era of personalized cancer therapy is here. Advances in the field of immunotherapy have paved... more The era of personalized cancer therapy is here. Advances in the field of immunotherapy have paved the way for the development of individualized neoantigen-based therapies that can translate into favorable treatment outcomes and fewer side effects for patients. Addressing challenges related to the identification, access, and clinical application of neoantigens is critical to accelerating the development of individualized immunotherapy for cancer patients.
Cancer Epidemiology, Biomarkers & Prevention
Melanoma is the fifth most commonly diagnosed cancer in the United States (US), and its incidence... more Melanoma is the fifth most commonly diagnosed cancer in the United States (US), and its incidence has been rapidly increasing within the past several decades. Previous studies have shown that individuals with darker skin tones are less likely to survive melanoma than those with lighter skin tones. Despite this increased morbidity in skin of color populations, limited studies have investigated how melanoma affects different races and ethnicities. Herein, we conducted a population-based registry study to assess the incidence and survival pattern of cutaneous malignant melanoma (CMM) subtypes in the US from 2006 to 2017. In addition, we examined the four major histological CMM subtypes (superficial spreading, lentigo maligna, nodular, and acral lentiginous melanoma) and its distribution by race, gender, and tumor grade. Data from 17 population-based cancer registries from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute were reviewed, and ...
Uploads
Papers by Michelle Samaniego